Merck to buy drug developer Pandion Therapeutics for $1.85 bln

Shares of Pandion rose 131.6% to a record high of $59.37 before the bell, while Merck shares were up about 1%. Pandion's lead drug candidate, PT101, met its main goals of safety and tolerability last month in an early-stage trial in patients with autoimmune diseases. Merck was represented by Credit Suisse Securities, Covington & Burling, while Centerview Partners LLC and Skadden, Arps, Slate, Meagher & Flom LLP represented Pandion.

Reuters | Updated: 25-02-2021 18:14 IST | Created: 25-02-2021 18:09 IST
Merck to buy drug developer Pandion Therapeutics for $1.85 bln
Representative image. Image Credit: Wikimedia

Merck & Co Inc said on Thursday it would buy drug developer Pandion Therapeutics Inc for about $1.85 billion in cash, expanding its portfolio of drugs that target autoimmune diseases.

The $60-per-share deal represents about 134% premium to Pandion's closing price on Wednesday. Shares of Pandion rose 131.6% to a record high of $59.37 before the bell, while Merck shares were up about 1%.

Pandion's lead drug candidate, PT101, met its main goals of safety and tolerability last month in an early-stage trial in patients with autoimmune diseases. In November, Merck agreed to buy privately-held VelosBio for $2.75 billion to strengthen its cancer drug portfolio as the drugmaker looks to reduce its reliance on its blockbuster cancer therapy Keytruda.

The deal between Merck and Pandion is expected to close in the first half of 2021, the companies said in a joint statement. Merck was represented by Credit Suisse Securities, Covington & Burling, while Centerview Partners LLC and Skadden, Arps, Slate, Meagher & Flom LLP represented Pandion.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Viral variants and vaccine nationalism pose two-pronged threat to Covid victory

... ...

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

World Water Day sees crises of inequality in countries both rich and poor

... ...

Videos

Latest News

Gunman who killed 8 workers at Indianapolis FedEx site had been detained for mental illness

The gunman who opened fire at a FedEx site in Indianapolis, killing eight workers, then himself, was a 19-year-old former employee with a history of mental illness that led to his detention by law enforcement last year, police and FBI offic...

Reuters Sports News Summary

Following is a summary of current sports news briefs.World champion Colemans ban reduced but he still misses OlympicsWorld 100 metres champion Christian Coleman had his two-year ban for breaching anti-doping whereabouts rules reduced to 18 ...

Reuters US Domestic News Summary

Following is a summary of current US domestic news briefs.NASA rules, Musk says as SpaceX wins 2.9 billion moon lander contractNASA awarded billionaire entrepreneur Elon Musks space company SpaceX a 2.9 billion contract to build a spacecraf...

Reuters World News Summary

Following is a summary of current world news briefs.Castro era in Cuba to end as Raul confirms hes retiringRaul Castro confirmed he was handing over the leadership of the Cuban Communist Party to a younger generation at its congress that ki...

Give Feedback